Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel therapeutic approaches to the treatment of metastatic breast cancer.
Fernández Y, Cueva J, Palomo AG, Ramos M, de Juan A, Calvo L, García-Mata J, García-Teijido P, Peláez I, García-Estévez L. Fernández Y, et al. Among authors: pelaez i. Cancer Treat Rev. 2010 Feb;36(1):33-42. doi: 10.1016/j.ctrv.2009.10.001. Epub 2009 Nov 1. Cancer Treat Rev. 2010. PMID: 19883980 Review.
Breast cancer management in the elderly.
Luque M, Arranz F, Cueva JF, de Juan A, García-Teijido P, Calvo L, Peláez I, García-Palomo A, García-Mata J, Antolín S, García-Estévez L, Fernández Y. Luque M, et al. Among authors: pelaez i. Clin Transl Oncol. 2014 Apr;16(4):351-61. doi: 10.1007/s12094-013-1113-2. Epub 2013 Oct 2. Clin Transl Oncol. 2014. PMID: 24085574 Review.
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM).
González A, Lluch A, Aba E, Albanell J, Antón A, Álvarez I, Ayala F, Barnadas A, Calvo L, Ciruelos E, Cortés J, de la Haba J, López-Vega JM, Martínez E, Muñoz M, Peláez I, Redondo A, Rodríguez Á, Rodríguez CA, Ruíz A, Llombart A. González A, et al. Among authors: pelaez i. Clin Transl Oncol. 2017 May;19(5):616-624. doi: 10.1007/s12094-016-1571-4. Epub 2016 Nov 16. Clin Transl Oncol. 2017. PMID: 27853985 Review.
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143).
Viéitez JM, Valladares M, Peláez I, de Sande González L, García-Foncillas J, García-López JL, García-Girón C, Reboredo M, Bovio H, Lacave AJ. Viéitez JM, et al. Among authors: pelaez i. Invest New Drugs. 2011 Oct;29(5):1038-44. doi: 10.1007/s10637-010-9400-z. Epub 2010 Mar 6. Invest New Drugs. 2011. PMID: 20204674 Clinical Trial.
Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial.
Smith I, Pierga JY, Biganzoli L, Cortes-Funes H, Thomssen C, Saracchini S, Nisenbaum B, Pelaez I, Duenne AA, Pritchard KI. Smith I, et al. Among authors: pelaez i. Breast Cancer Res Treat. 2011 Nov;130(1):133-43. doi: 10.1007/s10549-011-1695-8. Epub 2011 Aug 10. Breast Cancer Res Treat. 2011. PMID: 21830015 Clinical Trial.
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer.
Vieitez JM, Valladares M, Gracia M, Gonzalez-Barón M, Martín G, Mel JR, Rodríguez R, Constenla M, Gómez Aldavarí JL, Domínguez S, Dorta J, García-Girón C, López R, Sevilla I, Esteban E, Antón LM, Peláez I, López E, Lacave AJ. Vieitez JM, et al. Among authors: pelaez i. Lung Cancer. 2003 Jan;39(1):77-84. doi: 10.1016/s0169-5002(02)00387-2. Lung Cancer. 2003. PMID: 12499098 Clinical Trial.
51 results